DPP4 and diabetes mellitus: Stratification according to pre-study diabetes treatment regimens, amongst which were switches from another sulfonylurea or a dipeptidyl peptidase-4 inhibitor (DPP-4i), revealed significant HbA1c improvements with gliclazide MR in all four strata examined (Fig. 3a; P < 0.001).